Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (Q4)Mar 31, 2020 | (Q3)Dec 31, 2019 | (Q2)Sep 30, 2019 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 4.45%4.09B | -12.14%3.91B | -30.61%4.46B | 0.96%6.42B | -0.53%6.36B | 2.23B | -75.61%210M | 243.17%1.91B | -39.81%2.01B | 60.27%6.39B |
Net profit before non-cash adjustment | -33.75%2.27B | 33.97%3.43B | 34.79%2.56B | -23.60%1.9B | -45.38%2.49B | --59M | -16.84%963M | 12.77%883M | -40.55%582M | 3.76%4.55B |
Total adjustment of non-cash items | 126.96%2.66B | -55.91%1.17B | 4.32%2.66B | -15.82%2.55B | 75.78%3.03B | --853M | 19.56%1.02B | -29.84%362M | 4.91%791M | 26.80%1.72B |
-Depreciation and amortization | 1.38%2.8B | 8.33%2.76B | 8.67%2.55B | -0.43%2.34B | 1.07%2.35B | --603M | 0.85%590M | 0.69%586M | 0.53%573M | 18.72%2.33B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -88.89%12M | --108M | ---- | ---- | ---- | ---- | ---- |
-Share of associates | -875.00%-39M | -123.53%-4M | 241.67%17M | -166.67%-12M | --18M | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | 99.35%-10M | -2,337.68%-1.54B | -55.77%69M | 6.12%156M | 1,737.50%147M | ---86M | 87.50%15M | 127.78%41M | 1,670.00%177M | -97.05%8M |
-Other non-cash items | -132.43%-86M | -237.04%-37M | -46.00%27M | -87.56%50M | 165.58%402M | --210M | 86.59%487M | -300.00%-336M | -76.44%41M | 29.78%-613M |
Changes in working capital | -22.03%-842M | 10.04%-690M | -138.95%-767M | 133.85%1.97B | 619.66%842M | --1.32B | -54.65%-1.78B | 190.14%667M | -60.33%634M | 106.66%117M |
-Change in receivables | 69.42%-437M | -90.03%-1.43B | -1,075.00%-752M | -102.27%-64M | 9,193.55%2.82B | --1.56B | 2.15%-772M | 131.77%95M | 60.95%1.93B | 97.75%-31M |
-Change in inventory | 53.89%-546M | -149.26%-1.18B | -134.95%-475M | 357.87%1.36B | -631.94%-527M | ---28M | -16.06%-289M | 13,075.00%519M | -154.90%-729M | 93.95%-72M |
-Change in prepaid assets | 103.57%7M | -176.86%-196M | 204.51%255M | -12,300.00%-244M | --2M | ---- | ---- | ---- | ---- | ---- |
-Change in payables | -93.48%126M | 2,643.42%1.93B | -790.91%-76M | 100.81%11M | -1,294.69%-1.35B | ---688M | -124.72%-155M | 556.25%292M | -243.71%-799M | -85.25%113M |
-Change in accrued expense | -2,275.00%-87M | 100.80%4M | -182.95%-501M | 487.18%604M | -200.00%-156M | ---34M | -35.71%-133M | 389.13%225M | 36.50%-214M | 418.37%156M |
-Provision for loans, leases and other losses | -61.54%45M | -29.09%117M | -45.54%165M | 461.11%303M | 210.20%54M | --506M | 19.31%-518M | 10.02%-377M | -4.53%443M | -150.00%-49M |
-Changes in other current liabilities | -23.08%50M | -89.47%65M | --617M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0.00%-37M | 0.00%-37M | 0.00%-37M | 7.50%-37M | 20.00%-40M | -5M | 17.65%-14M | 44.44%-5M | 0.00%-16M | -6.38%-50M |
Interest received (cash flow from operating activities) | 25.93%34M | 8.00%27M | 108.33%25M | -42.86%12M | 10.53%21M | 3M | 16.67%7M | 0.00%2M | 0.00%9M | -5.00%19M |
Tax refund paid | 13.65%-898M | -175.13%-1.04B | 21.74%-378M | 51.51%-483M | 23.62%-996M | 14M | 13.37%-570M | 2,800.00%54M | 27.46%-494M | -44.73%-1.3B |
Other operating cash inflow (outflow) | 0 | 5,400.00%53M | 0.00%-1M | -100.25%-1M | -23.00%405M | 405M | 0 | 0 | 0 | 214.97%526M |
Operating cash flow | 9.26%3.19B | -28.22%2.92B | -31.25%4.06B | 2.82%5.91B | 2.95%5.75B | --2.65B | -290.16%-367M | 191.95%1.96B | -43.07%1.51B | 72.99%5.58B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -296.98%-3.55B | 64.88%-893M | -22.38%-2.54B | -221.17%-2.08B | 86.16%-647M | --710M | 45.63%-479M | 85.90%-300M | 61.34%-578M | 6.18%-4.68B |
Net intangibles purchase and sale | 56.33%-138M | 45.80%-316M | 3.00%-583M | -119.34%-601M | -149.09%-274M | ---194M | 50.00%-28M | -107.14%-29M | -15.00%-23M | -42.86%-110M |
Net investment product transactions | -111.11%-5M | -78.16%45M | 368.18%206M | 114.47%44M | -790.91%-304M | ---199M | -2,525.00%-105M | --0 | --0 | 91.30%44M |
Net changes in other investments | -136.36%-4M | -50.00%11M | 105.09%22M | -178.71%-432M | -15,400.00%-155M | ---12M | -47.22%19M | ---103M | ---59M | 0.00%-1M |
Investing cash flow | -220.21%-3.69B | 60.21%-1.15B | 5.51%-2.9B | -122.25%-3.07B | 70.90%-1.38B | --305M | 34.48%-593M | 79.57%-432M | 56.44%-660M | 5.87%-4.74B |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
Net common stock issuance | -139.57%-448M | ---187M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | 3.51%-55M | 17.39%-57M | 20.69%-69M | 32.56%-87M | 14.57%-129M | ---26M | -36.36%-45M | 44.19%-24M | 22.73%-34M | 18.82%-151M |
Cash dividends paid | -15.92%-721M | -0.16%-622M | 9.21%-621M | 12.98%-684M | 4.96%-786M | --0 | ---1M | 100.00%2M | 4.95%-787M | -11.01%-827M |
Net other fund-raising expenses | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | ---- | ---- | ---- | ---- | 66.67%-1M |
Financing cash flow | -41.29%-1.23B | -25.47%-867M | 10.49%-691M | 15.72%-772M | 6.44%-916M | ---27M | -36.36%-45M | 97.79%-23M | -172.91%-821M | -4.82%-979M |
Net cash flow | ||||||||||
Beginning cash position | 6.56%14.75B | 3.75%13.84B | 18.37%13.34B | 44.12%11.27B | -1.77%7.82B | --8.35B | 20.86%9.35B | -23.25%7.85B | -1.77%7.82B | -25.67%7.96B |
Current changes in cash | -292.87%-1.73B | 88.84%897M | -77.08%475M | -39.99%2.07B | 2,602.17%3.45B | --2.93B | -34.90%-1.01B | 160.52%1.5B | -98.85%26M | 94.97%-138M |
Effect of exchange rate changes | 145.45%27M | -56.00%11M | --25M | --0 | 0.00%-2M | ---2M | --0 | 200.00%1M | -200.00%-1M | 50.00%-2M |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---1M | ---- | ---- | ---- | ---- | -200.00%-1M | 0.00%-1M |
End cash Position | -11.54%13.05B | 6.56%14.75B | 3.75%13.84B | 18.37%13.34B | 44.12%11.27B | --11.27B | 19.43%8.35B | 20.86%9.35B | -23.25%7.85B | -1.77%7.82B |
Free cash flow | -2,722.73%-577M | -97.65%22M | -70.94%938M | -25.07%3.23B | 451.60%4.31B | --2.65B | -17.47%-874M | 212.10%1.63B | -18.74%906M | 142.47%781M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |